Walking just under 4,000 steps a day may be enough to cut risk of early death, according to a new study
Walking just under 4,000 steps a day may be enough to cut risk of early death, a new study has claimed.
Scientists found that walking at least 3,967 steps daily helped a person start to reduce their risk of dying from any cause. In addition, getting 2,337 steps a day helped to reduce the risk of heart disease deaths. Indeed an extra 1,000 steps a day was associated with a 15 per cent reduction in the risk of dying from any cause, and an increase of 500 steps a day was associated with a 7 per cent reduction in dying from cardiovascular disease.
“In addition, our analysis indicates that as little as 4,000 steps a day are needed to significantly reduce deaths from any cause, and even fewer to reduce deaths from cardiovascular disease.”
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Urgent police appeal over missing man last seen walking on Oxford RoadOfficers have released a CCTV image
Lire la suite »
Car deliberately set on fire at popular walking spotFire crews from Stapleford attended the scene
Lire la suite »
Thieves strolled out with $300,000 worth of TCG cards in Gen Con heistCCTV images show two suspected thieves walking out of the convention last week.
Lire la suite »
Association between troponin level and medium-term mortality in 20 000 hospital patientsIntroduction Cardiac troponin (cTn) concentrations above the manufacturer recommended upper limit of normal (ULN) are frequently seen in hospital patients without a clinical presentation consistent with type 1 myocardial infarction, and the significance of this is uncertain. The aim of this study was to assess the relationship between medium-term mortality and cTn concentration in a large consecutive hospital population, regardless of whether there was a clinical indication for performing the test. Method This prospective observational study included 20 000 consecutive in-hospital and outpatient patients who had a blood test for any reason at a large teaching hospital, and in whom a hs-cTnI assay was measured, regardless of the original clinical indication. Mortality was obtained via NHS Digital. Results A total of 20 000 patients were included in the analysis and 18 282 of these (91.4%) did not have a clinical indication for cardiac troponin I (cTnI) testing. Overall, 2825 (14.1%) patients died at a median of 809 days. The mortality was significantly higher if the cTnI concentration was above the ULN (45.3% vs 12.3% p|0.001 log rank). Multivariable Cox analysis demonstrated that the log10 cTnI concentration was independently associated with mortality (HR 1.76 (95% CI 1.65 to 1.88)). Landmark analysis, excluding deaths within 30 days, showed the relationship between cTnI concentration and mortality persisted. Conclusion In a large, unselected hospital population, in 91.4% of whom there was no clinical indication for testing, cTnI concentration was independently associated with medium-term cardiovascular and non-cardiovascular mortality in the statistical model tested. No data are available. The nature of the data sharing agreement with NHS Digital prevents sharing of these data.
Lire la suite »
Man remanded in custody over M62 crash death of boy, 12Callum Rycroft was killed while walking on the eastbound carriageway of the motorway between junctions 25 and 26 on Saturday evening.
Lire la suite »